Recombinant ADAMTS13 normalizes von Willebrand factor‐cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies

Publisher: John Wiley & Sons Inc

E-ISSN: 1538-7836|9|5|936-944

ISSN: 1538-7933

Source: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.9, Iss.5, 2011-05, pp. : 936-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract